Corticosteroids Comparison Guide: Prednisone, Dexamethasone, Hydrocortisone and More (2025)

• Corticosteroids mimic cortisol, a naturally occurring hormone, and are among the most potent anti-inflammatory and immunosuppressive medications available.
• Potency varies significantly between agents -- dexamethasone is 25-30 times more potent than cortisol, while prednisone is 4-5 times more potent.
• Duration of action matters -- short-acting (hydrocortisone), intermediate-acting (prednisone, methylprednisolone), and long-acting (dexamethasone, betamethasone) agents are selected based on the clinical situation.
• Side effects are dose- and duration-dependent -- short courses (1-2 weeks) carry minimal long-term risk, while chronic therapy requires careful monitoring for osteoporosis, diabetes, hypertension, and adrenal suppression.
• Never stop long-term corticosteroids abruptly -- tapering is essential to allow the adrenal glands to resume natural cortisol production and prevent life-threatening adrenal crisis.

Corticosteroids (often called "steroids") are synthetic drugs that closely resemble cortisol, a hormone produced by the adrenal glands. Cortisol plays essential roles in metabolism, immune response regulation, and stress response. Synthetic corticosteroids harness and amplify cortisol's anti-inflammatory and immunosuppressive properties.

The term "corticosteroid" encompasses both glucocorticoids (which have anti-inflammatory and metabolic effects) and mineralocorticoids (which regulate sodium and water balance). In clinical practice, when people refer to "steroids," they are almost always talking about glucocorticoids.

Corticosteroids act by binding to intracellular glucocorticoid receptors, which then translocate to the cell nucleus and modify gene expression. This results in:

• Suppression of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha)
• Inhibition of phospholipase A2, reducing prostaglandin and leukotriene production
• Reduction of white blood cell migration to sites of inflammation
• Suppression of the adaptive immune response by reducing T-cell activation and antibody production

Relative Potency Comparison

Inhaled Corticosteroids (For Respiratory Conditions)

Hydrocortisone

Hydrocortisone is the synthetic form of cortisol and is closest to the body's natural hormone. It is prescribed for:

• Adrenal insufficiency (Addison's disease) -- physiologic replacement therapy
• Acute adrenal crisis -- emergency IV administration
• Congenital adrenal hyperplasia -- hormone replacement
• Topical use -- mild skin inflammation, eczema, insect bites
• Septic shock -- low-dose IV hydrocortisone in refractory shock (200 mg/day)

Because of its significant mineralocorticoid activity, hydrocortisone causes more fluid retention and hypertension than synthetic agents at equivalent anti-inflammatory doses. This property makes it ideal for adrenal replacement (where both glucocorticoid and mineralocorticoid effects are needed) but less ideal for purely anti-inflammatory purposes.

Prednisone and Prednisolone

Prednisone (a prodrug converted to prednisolone in the liver) and prednisolone are the most commonly used oral corticosteroids for inflammatory and autoimmune conditions. They are prescribed for:

• Rheumatoid arthritis and other autoimmune diseases (SLE, vasculitis, polymyalgia rheumatica)
• Asthma exacerbations -- short courses (5-14 days)
• COPD exacerbations -- short courses
• Acute gout -- when NSAIDs are contraindicated
• Inflammatory bowel disease (Crohn's disease, ulcerative colitis) flares
• Nephrotic syndrome and other kidney diseases
• Organ transplant rejection prevention -- part of immunosuppressive regimens
• Multiple sclerosis relapses -- high-dose short courses

Prednisolone is preferred over prednisone in patients with significant liver disease (because conversion is not required) and in pediatric populations.

Methylprednisolone

Methylprednisolone offers slightly greater anti-inflammatory potency than prednisone with less mineralocorticoid activity. It is prescribed for:

• Acute spinal cord injury -- high-dose IV protocol (though evidence for benefit has been debated)
• Multiple sclerosis relapses -- high-dose IV pulses
• Severe autoimmune flares -- IV pulse therapy for lupus nephritis, vasculitis
• Status asthmaticus -- IV administration when oral route unavailable
• Nausea/vomiting of pregnancy -- at low doses (alternative to prednisone)

IV methylprednisolone pulse therapy (500-1000 mg/day for 3-5 days) is used for severe autoimmune and inflammatory conditions requiring rapid, high-intensity immunosuppression.

Dexamethasone

Dexamethasone is a long-acting, highly potent corticosteroid with no significant mineralocorticoid activity. It is prescribed for:

• Cerebral edema (brain tumors, traumatic brain injury) -- reduces intracranial pressure
• COVID-19 (hospitalized patients requiring oxygen) -- RECOVERY trial showed 23% mortality reduction
• Nausea and vomiting -- chemotherapy-induced (often combined with ondansetron)
• Croup in children -- single dose (0.6 mg/kg)
• Preterm labor -- accelerates fetal lung maturation (given to the mother)
• Adrenal suppression testing -- dexamethasone suppression test for Cushing's syndrome
• Multiple myeloma and other hematologic malignancies -- part of chemotherapy regimens
• Severe airway inflammation -- when maximal anti-inflammatory effect is needed

Because dexamethasone has no mineralocorticoid activity, it does not cause significant fluid retention, making it preferred when sodium and water retention must be avoided (such as in cerebral edema).

Short-Term Side Effects (Days to Weeks)

Long-Term Side Effects (Months to Years)

Major Interactions

• NSAIDs -- Additive GI toxicity; increased risk of peptic ulcers and GI bleeding. Avoid combination when possible; use PPI if co-administration is necessary.
• Warfarin and anticoagulants -- Corticosteroids can alter anticoagulant response, increasing or decreasing INR unpredictably. More frequent INR monitoring is needed.
• Diabetes medications -- Corticosteroids raise blood glucose and may reduce the effectiveness of insulin, metformin, and other hypoglycemic agents. Dose adjustments are often needed.
• Live vaccines -- Should be avoided in patients receiving immunosuppressive doses of corticosteroids (>20 mg/day prednisone equivalent for >2 weeks) due to risk of vaccine-derived infection.
• CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) -- Can increase corticosteroid levels and toxicity.
• CYP3A4 inducers (rifampin, phenytoin, carbamazepine, barbiturates) -- Can decrease corticosteroid levels and reduce efficacy.
• Diuretics (especially potassium-wasting) -- Additive potassium loss with corticosteroids; monitor potassium closely.
• Digoxin -- Corticosteroid-induced hypokalemia can increase digoxin toxicity risk.
• Cyclosporine -- Mutual inhibition of metabolism; increased levels of both drugs.

Before Starting Therapy

• Baseline blood glucose and HbA1c
• Blood pressure
• Bone density (DEXA scan) if therapy is expected to last more than 3 months
• Tuberculosis screening (quantiferon or PPD) if high risk
• Hepatitis B and C screening if high risk
• Complete blood count (CBC) and comprehensive metabolic panel
• Eye exam if therapy expected to exceed 1 year
• Vitamin D level

During Therapy

• Blood glucose -- every 1-3 months for long-term therapy
• Blood pressure -- at each visit
• Weight -- at each visit
• CBC and metabolic panel -- every 3-6 months
• DEXA scan -- annually for chronic therapy
• Eye examination -- annually for therapy exceeding 1 year
• Growth monitoring -- in pediatric patients (height and weight percentiles)
• Adrenal function -- morning cortisol when tapering long-term therapy

Tapering Protocol

Tapering is necessary when corticosteroids have been used at supraphysiologic doses (greater than 5 mg/day prednisone equivalent) for more than 2-3 weeks. General principles:

• Short courses (less than 2 weeks): Can often be stopped without tapering
• Moderate duration (2-4 weeks): Taper over 1-2 weeks
• Long-term therapy (months to years): Taper slowly over weeks to months
  • Reduce dose by 10-20% every 1-2 weeks until reaching physiologic dose (5-7.5 mg/day prednisone)
  • Below physiologic dose, taper by 1 mg every 2-4 weeks
  • Monitor for symptoms of adrenal insufficiency: fatigue, weakness, nausea, hypotension, body aches
  • Consider morning cortisol testing to assess adrenal recovery before final discontinuation

Timing of Doses

• Take corticosteroids in the morning (before 9 AM) to mimic the body's natural cortisol rhythm and reduce insomnia.
• If taking twice daily, take the larger dose in the morning and the smaller dose in the early afternoon (before 2 PM).
• With food to reduce GI irritation.

Diet and Lifestyle

• Calcium: 1200-1500 mg/day through diet and supplements
• Vitamin D: 800-1000 IU/day (or higher if deficient)
• Sodium restriction: Especially with hydrocortisone and prednisone, which have mineralocorticoid activity
• Protein intake: Maintain adequate protein to help prevent muscle wasting
• Weight-bearing exercise: Helps protect against osteoporosis
• Alcohol: Limit intake as it increases osteoporosis risk
• Smoking cessation: Smoking compounds bone loss risk

Inhaled Corticosteroid Considerations

• Rinse mouth after use to prevent oral thrush (candidiasis)
• Use a spacer device with metered-dose inhalers to improve lung delivery and reduce oral deposition
• Systemic absorption is minimal at standard doses, but high-dose inhaled steroids can cause systemic effects
• Growth suppression in children is a concern with high-dose inhaled corticosteroids, though the effect is generally small and reversible

1. Why do I need to taper steroids instead of just stopping them?

When you take corticosteroids for more than 2-3 weeks, your adrenal glands reduce or stop their own cortisol production because the medication is providing what the body needs. If you stop suddenly, your adrenal glands cannot immediately resume cortisol production, leading to adrenal crisis -- a potentially life-threatening condition with symptoms including severe fatigue, low blood pressure, nausea, vomiting, and shock. Tapering gives the adrenal glands time to gradually resume natural cortisol production.

2. Will I gain weight on corticosteroids?

Weight gain is common, especially with longer courses and higher doses. It occurs through several mechanisms: increased appetite, fluid retention (particularly with prednisone and hydrocortisone), and redistribution of body fat (increased abdominal fat, "moon face," and fat at the back of the neck). Short courses (1-2 weeks) typically cause minimal weight changes. Long-term users can minimize weight gain through portion control, low-sodium diet, and regular exercise.

3. Can I drink alcohol while taking corticosteroids?

Alcohol should be limited or avoided while on corticosteroids. Both alcohol and corticosteroids increase the risk of osteoporosis, GI bleeding, and elevated blood sugar. The combination also increases the risk of stomach ulcers. If you do drink, keep it to no more than one drink per day and discuss it with your doctor.

4. How long does it take for corticosteroids to start working?

Oral corticosteroids typically begin reducing inflammation within 4-6 hours of the first dose. Peak effects may take 24-48 hours. For acute conditions like asthma exacerbations, patients often notice improvement within 12-24 hours. Inhaled corticosteroids take longer to reach full effect -- typically 1-2 weeks for noticeable improvement and up to 4-8 weeks for maximum benefit.

5. Are inhaled corticosteroids as dangerous as oral steroids?

No. Inhaled corticosteroids deliver medication directly to the lungs with minimal systemic absorption. At standard doses, they carry a much lower risk of systemic side effects like osteoporosis, diabetes, and adrenal suppression compared to oral corticosteroids. The main side effects are local: oral thrush and hoarseness. Using a spacer device and rinsing your mouth after use can significantly reduce these local effects.

6. What is a "steroid-sparing" agent?

Steroid-sparing agents are medications (such as methotrexate, azathioprine, mycophenolate, or biologics) that are added to a treatment regimen to control the underlying disease, allowing the corticosteroid dose to be reduced or eventually eliminated. They are used in chronic inflammatory and autoimmune conditions to minimize long-term steroid exposure while maintaining disease control.